AACS: African Americans (AA) Communities Speak

Sponsor
University of Alabama at Birmingham (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05908487
Collaborator
Montefiore Medical Center (Other), University of California, San Francisco (Other), University of Massachusetts, Worcester (Other)
60
4
60

Study Details

Study Description

Brief Summary

African Americans are less likely to receive quality end-of-life (EoL) care. Addressing disparities in EoL care will need efforts to support a better understanding of African American patients' EoL cultural values and preferences for EoL communication and the impact of historical and ongoing care delivery inequities in healthcare settings.

Our proposed "Caring for Older African Americans" training program is designed to empower clinicians to improve goal-concordant EoL care delivery by using community-developed storytelling videos to create empathy with experiences of racism in EoL care, guidelines for culturally concordant EoL care delivery, and an implicit bias recognition and management training to mitigate bias in goals of care communication.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: AA Communities Speak to Healthcare Professionals
N/A

Detailed Description

African Americans (AA) are less likely to receive quality end-of-life (EoL) care. For example, goals of care conversations, which are critical discussions between clinicians, patients, and families near the end of life, are less likely to occur for AAs than for Whites, and preferences are less likely to be followed when they do occur. Instead, families are more likely to be labeled as "difficult" if their decisions are incongruent with clinicians' recommendations. EoL decisions for many AA persons are rooted in both culture and a lifetime of experiences of structural racism. Efforts to address disparities need to address multiple factors such as patient-level cultural identity and EoL care values, interpersonal- and community-level norms for EoL communication and treatment, and healthcare institutional contexts for delivering EoL care in a setting affected by institutional racism.

Our research group began to address this need with 'African American Community Speaks', a proof-of-concept prototype of a community-developed training program for clinicians caring for AA older adults with serious illnesses. The program originally focused on rural Southern older AAs and is not broadly generalizable across the US due to geographic differences in culture, attitudes, and communication preferences among AA persons in the US. Thus, we propose to adapt our prototype program to urban-dwelling Southern and Northern older AA adults using our established platform of Community-Based Participatory Research (CBPR) in two geographically diverse regions: Birmingham, Alabama, and the Bronx, New York. To create the new training program called 'Caring for Older African Americans', our team of experts in CBPR, medical sociology, and clinical trials will work with local Community Advisory Boards to: 1. Conduct a comparative ethnographic study of urban dwelling AAs in the North and South to describe AA community values and preferences related to EoL care; 2. Adaptation of our prior community-developed training program by integrating community-developed storytelling videos for empathizing with experiences of racism in EoL care, guidelines for culturally concordant EoL care delivery, and adapting an existing implicit bias management program to goals of care communication; and 3. Conduct a cluster randomized trial in which we will randomize training times to 1 of 4 start dates using a stepped wedge design to accommodate the training of all clinicians and to mitigate the effect of secular trends.

Patients' personal experience of racism will be measured using the discrimination subscale of the Group Based Mistrust Scale. The primary outcome will be patient/family's perception of therapeutic alliance using The Human Connection Scale. Secondary outcomes will be family-reported goal-concordant care, and clinicians' knowledge of cultural values, awareness of implicit bias, and confidence to change practice. This innovative effort will be the first training program that: 1. addresses culturally concordant care, systemic racism, and implicit bias management, the three key elements in enhancing the provision of equitable care; and 2. is designed and implemented in full partnership with two distinct AA communities in the South and the North of the US.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Health Services Research
Official Title:
African Americans (AA) Communities Speak: Partnering With AA in the North and South to Train Palliative Care Clinicians to Address Interpersonal and Systemic Racism and Provide Culturally Aligned Care.
Anticipated Study Start Date :
Jul 1, 2023
Anticipated Primary Completion Date :
Jul 1, 2027
Anticipated Study Completion Date :
Jul 1, 2028

Arms and Interventions

Arm Intervention/Treatment
Other: Clinician Trainees- Cluster 1

Within each participating institution, clinician clusters are randomized to 1 of 4 start date training times for the African American Communities Speak (AACS) Education Intervention. Each arm has a pre-intervention (control) period and a post-intervention (exposure) period.

Behavioral: AA Communities Speak to Healthcare Professionals
The training program is designed to empower clinicians to improve goal-concordant EoL care delivery by using community-developed storytelling videos to create empathy with experiences of racism in EoL care, guidelines for culturally concordant EoL care delivery, and implicit bias recognition and management training to mitigate bias in goals of care communication.
Other Names:
  • Clinician Training
  • Other: Clinician Trainees- Cluster 2

    Within each participating institution, clinician clusters are randomized to 1 of 4 start date training times for the African American Communities Speak (AACS) Education Intervention. Each arm has a pre-intervention (control) period and a post-intervention (exposure) period

    Behavioral: AA Communities Speak to Healthcare Professionals
    The training program is designed to empower clinicians to improve goal-concordant EoL care delivery by using community-developed storytelling videos to create empathy with experiences of racism in EoL care, guidelines for culturally concordant EoL care delivery, and implicit bias recognition and management training to mitigate bias in goals of care communication.
    Other Names:
  • Clinician Training
  • Other: Clinician Trainees- Cluster 3

    Within each participating institution, clinician clusters are randomized to 1 of 4 start date training times for the African American Communities Speak (AACS) Education Intervention. Each arm has a pre-intervention (control) period and a post-intervention (exposure) period

    Behavioral: AA Communities Speak to Healthcare Professionals
    The training program is designed to empower clinicians to improve goal-concordant EoL care delivery by using community-developed storytelling videos to create empathy with experiences of racism in EoL care, guidelines for culturally concordant EoL care delivery, and implicit bias recognition and management training to mitigate bias in goals of care communication.
    Other Names:
  • Clinician Training
  • Other: Clinician Trainees- Cluster 4

    Within each participating institution, clinician clusters are randomized to 1 of 4 start date training times for the African American Communities Speak (AACS) Education Intervention. Each arm has a pre-intervention (control) period and a post-intervention (exposure) period

    Behavioral: AA Communities Speak to Healthcare Professionals
    The training program is designed to empower clinicians to improve goal-concordant EoL care delivery by using community-developed storytelling videos to create empathy with experiences of racism in EoL care, guidelines for culturally concordant EoL care delivery, and implicit bias recognition and management training to mitigate bias in goals of care communication.
    Other Names:
  • Clinician Training
  • Outcome Measures

    Primary Outcome Measures

    1. Human Connection Scale (patient/family reported) [up to 3 months before the intervention]

      The Human Connection (THC) Scale is a summary score of item responses such that a higher total score indicates greater therapeutic alliance. Possible scores range from 16 to 64. The 16-item THC scale had a high degree of internal consistency (Cronbach α= 90).

    2. Human Connection Scale (patient/ family reported) [up to 3 months after intervention]

      The Human Connection (THC) Scale is a summary score of item responses such that a higher total score indicates greater therapeutic alliance. Possible scores range from 16 to 64. The 16-item THC scale had a high degree of internal consistency (Cronbach α= 90).

    Secondary Outcome Measures

    1. Goal Concordant Care (patient/family reported) [up to 3 months before the intervention]

      Goal Concordant Care will be measured based on responses to the following two questions, each with a dichotomous outcome: 1. Family member reports that the patient's end-of-life wishes were adequately discussed with the family respondent 2. Family member's satisfaction that patient's end-of-life were met. Johnson, S.B., Butow, P.N., Bell, M.L. et al. A randomized controlled trial of an advance care planning intervention for patients with incurable cancer. Br J Cancer 119, 1182-1190 (2018). https://doi.org.10.1038/s41416-018-0303-7

    2. Goal Concordant Care (patient/family reported) [up to 3 months after the intervention]

      Goal Concordant Care will be measured based on responses to the following two questions, each with a dichotomous outcome: 1. Family member reports that the patient's end-of-life wishes were adequately discussed with the family respondent 2. Family member's satisfaction that patient's end-of-life were met. Johnson, S.B., Butow, P.N., Bell, M.L. et al. A randomized controlled trial of an advance care planning intervention for patients with incurable cancer. Br J Cancer 119, 1182-1190 (2018). https://doi.org.10.1038/s41416-018-0303-7

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes

    Inclusion Criteria: Aim 1.1

    Person with serious Illness:
    • Self-identified as African American (i.e., born, raised, and lived primarily in the US)

    • Non-Hispanic or Latino

    • Age ≥60 years

    • English-speaking

    • Has been diagnosed with a condition that fits into one of 3 illness paradigms including cancer, cardiac disease, pulmonary disease, neuro-degenerative disease, renal disease, stroke, sepsis, hepatic disease)

    • Callahan Six-Item Screener score ≥4

    • Able to complete baseline surveys.

    Bereaved family member:
    • Self-identified as African American (i.e., born, raised, and lived primarily in the US)

    • Non-Hispanic or Latino

    • Age ≥60 years

    • English-speaking

    • Loved one dies in the last 12 months and was diagnosed with a condition that fits into one of 3 illness paradigms including cancer, cardiac disease, pulmonary disease, neuro- degenerative disease, renal disease, stroke, sepsis, hepatic disease)

    • Callahan Six-Item Screener score ≥4

    • Able to complete baseline surveys.

    Exclusion Criteria

    Person with serious illness:

    -Cannot be receiving hospice care

    Bereaved Family Member:

    -Cannot be a paid "sitter"

    Inclusion Criteria: Aim 1.2

    Bereaved Family member:
    • Self-identified as African American (i.e., born, raised, and lived primarily in the US)

    • Non-Hispanic or Latino

    • Age ≥60 years

    • English-speaking

    • Loved one dies in the last 12 months and was diagnosed with a condition that fits into one of 3 illness paradigms including cancer, cardiac disease, pulmonary disease, neuro- degenerative disease, renal disease, stroke, sepsis, hepatic disease)

    • Callahan Six-Item Screener score ≥4

    • Able to complete baseline surveys

    Pastors:
    • Self-identifying as African American

    • White, Non-Hispanic or Latino

    • Sged ≥18 years old.

    Inclusion Criteria: Aim 3

    Clinician eligibility:
    • Practice at a University of Alabama at Birmingham (UAB) or Montefiore/Einstein site that provides care to patients eligible for outcomes surveys

    • At least 3 months of clinical practice at the study site prior to the intervention training to measure pre-intervention patient surveys

    Exclusion criteria:

    -Lack of at least 3 months of clinical practice at the study site prior to the intervention training.

    Patient eligibility:
    • Self-identified as African American (i.e., born, raised, and lived primarily in the US)

    • Non-Hispanic or Latino, 3. age ≥60 years

    • English-speaking

    • Has been diagnosed with a condition that fits into one of 3 illness paradigms including cancer, cardiac disease, pulmonary disease, neuro-degenerative disease, renal disease, stroke, sepsis, hepatic disease)

    • Callahan Six-Item Screener score ≥4

    • Able to complete baseline surveys.

    Exclusion criteria include:

    -Currently receiving hospice care.

    Family member eligibility:
    • Age ≥ 18 years

    • English-speaking

    • Community-dwelling

    • Unpaid care provider of a person with a serious illness.

    Exclusion criteria: 1. Cannot be a paid "sitter".

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • University of Alabama at Birmingham
    • Montefiore Medical Center
    • University of California, San Francisco
    • University of Massachusetts, Worcester

    Investigators

    • Principal Investigator: Jennifer Tjia, MD, MSCE, University of Massachusetts, Worcester

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Ronit Elk, Associate Director, Center of Palliative and Supportive Care, University of Alabama at Birmingham
    ClinicalTrials.gov Identifier:
    NCT05908487
    Other Study ID Numbers:
    • IRB300007677
    First Posted:
    Jun 18, 2023
    Last Update Posted:
    Jun 18, 2023
    Last Verified:
    Jun 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Ronit Elk, Associate Director, Center of Palliative and Supportive Care, University of Alabama at Birmingham

    Study Results

    No Results Posted as of Jun 18, 2023